Published in PLoS Genet on August 18, 2011
Rare and common variants: twenty arguments. Nat Rev Genet (2012) 6.67
Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc (2013) 5.27
A mixed-model approach for genome-wide association studies of correlated traits in structured populations. Nat Genet (2012) 2.69
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet (2013) 2.44
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J (2012) 2.36
Advances in the genetics of Parkinson disease. Nat Rev Neurol (2013) 2.21
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Vitamin D from different sources is inversely associated with Parkinson disease. Mov Disord (2014) 1.67
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63
Multisystem Lewy body disease and the other parkinsonian disorders. Nat Genet (2015) 1.57
Informed conditioning on clinical covariates increases power in case-control association studies. PLoS Genet (2012) 1.57
The genetics and neuropathology of Parkinson's disease. Acta Neuropathol (2012) 1.56
Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet (2012) 1.52
Caffeine consumption and risk of dyskinesia in CALM-PD. Mov Disord (2013) 1.42
Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease. Neurol Genet (2017) 1.40
Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum Genet (2012) 1.37
Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases. Am J Hum Genet (2012) 1.30
Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy. Nat Commun (2014) 1.29
Simultaneously testing for marginal genetic association and gene-environment interaction. Am J Epidemiol (2012) 1.29
Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. Genet Epidemiol (2013) 1.27
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Mol Pharmacol (2015) 1.16
A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice. Neurotherapeutics (2012) 1.11
Genetic determinants of depression: recent findings and future directions. Harv Rev Psychiatry (2015) 1.02
Genome-wide association study of Arabidopsis thaliana leaf microbial community. Nat Commun (2014) 1.01
SBERIA: set-based gene-environment interaction test for rare and common variants in complex diseases. Genet Epidemiol (2013) 0.99
Oxidative stress in genetic mouse models of Parkinson's disease. Oxid Med Cell Longev (2012) 0.98
A robust model-free approach for rare variants association studies incorporating gene-gene and gene-environmental interactions. PLoS One (2013) 0.96
Identification of a novel Parkinson's disease locus via stratified genome-wide association study. BMC Genomics (2014) 0.93
A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. Pharmacogenomics J (2012) 0.91
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. Hum Mol Genet (2014) 0.90
Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population. PLoS One (2014) 0.89
A nonparametric test to detect quantitative trait loci where the phenotypic distribution differs by genotypes. Genet Epidemiol (2013) 0.88
Correcting systematic inflation in genetic association tests that consider interaction effects: application to a genome-wide association study of posttraumatic stress disorder. JAMA Psychiatry (2014) 0.88
Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease. PLoS Genet (2014) 0.86
Disclosure of genetic information and change in dietary intake: a randomized controlled trial. PLoS One (2014) 0.86
PharmGKB summary: caffeine pathway. Pharmacogenet Genomics (2012) 0.86
Gene-Environment Interactions in Asthma: Genetic and Epigenetic Effects. Yonsei Med J (2015) 0.86
Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease. PLoS One (2012) 0.85
Genome-wide interaction study identifies RCBTB1 as a modifier for smoking effect on carotid intima-media thickness. Arterioscler Thromb Vasc Biol (2013) 0.83
Modulation of genetic associations with serum urate levels by body-mass-index in humans. PLoS One (2015) 0.83
A perspective on interaction effects in genetic association studies. Genet Epidemiol (2016) 0.82
Additive influence of genetic predisposition and conventional risk factors in the incidence of coronary heart disease: a population-based study in Greece. BMJ Open (2014) 0.82
Molecular network analysis enhances understanding of the biology of mental disorders. Bioessays (2014) 0.82
Dietary factors in the etiology of Parkinson's disease. Biomed Res Int (2015) 0.81
Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective. Neurotherapeutics (2014) 0.79
Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clin Neuropharmacol (2015) 0.79
PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice. Neuroscience (2013) 0.79
Genetic associations with micronutrient levels identified in immune and gastrointestinal networks. Genes Nutr (2014) 0.79
Powerful Set-Based Gene-Environment Interaction Testing Framework for Complex Diseases. Genet Epidemiol (2015) 0.79
A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia. PLoS One (2017) 0.79
Microarray and qPCR Analyses of Wallerian Degeneration in Rat Sciatic Nerves. Front Cell Neurosci (2017) 0.78
Incorporating gene-environment interaction in testing for association with rare genetic variants. Hum Hered (2014) 0.78
Meta-Analysis of Genome-Wide Association Studies with Correlated Individuals: Application to the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Genet Epidemiol (2016) 0.78
Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity. Hum Genet (2015) 0.77
A genome-wide association study of antidepressant response in Koreans. Transl Psychiatry (2015) 0.77
Childhood gene-environment interactions and age-dependent effects of genetic variants associated with refractive error and myopia: The CREAM Consortium. Sci Rep (2016) 0.77
Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions. Parkinsonism Relat Disord (2013) 0.77
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset. Neurogenetics (2013) 0.77
Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese population. PLoS One (2013) 0.77
The role of linkage disequilibrium in case-only studies of gene-environment interactions. Hum Genet (2014) 0.76
Accounting for Population Structure in Gene-by-Environment Interactions in Genome-Wide Association Studies Using Mixed Models. PLoS Genet (2016) 0.76
Parkinson disease loci in the mid-western Amish. Hum Genet (2013) 0.76
Glutamate receptor gene GRIN2A, coffee, and Parkinson disease. PLoS Genet (2014) 0.76
Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease. Parkinsons Dis (2016) 0.76
A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma. Carcinogenesis (2016) 0.75
DNA variants in CACNA1C modify Parkinson disease risk only when vitamin D level is deficient. Neurol Genet (2016) 0.75
Expression Profiles of Long Noncoding RNAs and Messenger RNAs in Mn-Exposed Hippocampal Neurons of Sprague-Dawley Rats Ascertained by Microarray: Implications for Mn-Induced Neurotoxicity. PLoS One (2016) 0.75
Coffee consumption is associated with DNA methylation levels of human blood. Eur J Hum Genet (2017) 0.75
Identification of genetic modifiers of age-at-onset for familial Parkinson's disease. Hum Mol Genet (2016) 0.75
Caffeine, creatine, GRIN2A and Parkinson's disease progression. J Neurol Sci (2017) 0.75
A partition-based approach to identify gene-environment interactions in genome wide association studies. BMC Proc (2014) 0.75
Coffee, Genetic Variants, and Parkinson's Disease: Gene-Environment Interactions. J Caffeine Res (2015) 0.75
Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation? Mov Disord (2015) 0.75
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease. Sci Rep (2015) 0.75
Habitual coffee consumption and genetic predisposition to obesity: gene-diet interaction analyses in three US prospective studies. BMC Med (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Finding the missing heritability of complex diseases. Nature (2009) 67.95
A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81
A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet (2009) 30.09
PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res (2007) 19.07
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet (2011) 9.10
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology (2006) 6.86
Gene--environment-wide association studies: emerging approaches. Nat Rev Genet (2010) 6.10
Exploiting gene-environment interaction to detect genetic associations. Hum Hered (2007) 5.63
Dichotomous dopaminergic control of striatal synaptic plasticity. Science (2008) 5.47
Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet (2008) 5.04
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26
Accelerated evolution of nervous system genes in the origin of Homo sapiens. Cell (2004) 4.24
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain (2002) 4.16
Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study. Public Health Nutr (2007) 3.88
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol (2002) 3.87
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet (2010) 3.82
Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol (2009) 3.02
Avoiding the high Bonferroni penalty in genome-wide association studies. Genet Epidemiol (2010) 2.79
Start/stop signals emerge in nigrostriatal circuits during sequence learning. Nature (2010) 2.76
The use of inferred haplotypes in downstream analyses. Am J Hum Genet (2007) 2.16
Genetic analysis of pathways to Parkinson disease. Neuron (2010) 2.15
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci (2001) 1.90
Genome-wide association study of smoking initiation and current smoking. Am J Hum Genet (2009) 1.87
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nat Neurosci (2010) 1.81
Meta-analysis of gene-environment interaction: joint estimation of SNP and SNP × environment regression coefficients. Genet Epidemiol (2011) 1.71
Dopamine transporter genetic variants and pesticides in Parkinson's disease. Environ Health Perspect (2009) 1.63
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord (2008) 1.61
Genomewide SNP assay reveals mutations underlying Parkinson disease. Hum Mutat (2008) 1.49
Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.48
Exploring gene-environment interactions in Parkinson's disease. Hum Genet (2008) 1.43
Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet (2006) 1.42
Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann Neurol (2008) 1.34
Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav (2009) 1.32
Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. Arch Neurol (2007) 1.29
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet (2006) 1.26
Genome-wide meta-analysis of joint tests for genetic and gene-environment interaction effects. Hum Hered (2011) 1.22
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner. Hum Genet (2007) 1.13
Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease. Neurology (2003) 1.04
Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial. Parkinsonism Relat Disord (2009) 0.98
Glutamate, excitotoxicity, and programmed cell death in Parkinson disease. Exp Neurol (2009) 0.92
A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia. Pharmacogenetics (2003) 0.92
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum. J Neurosci Res (2004) 0.90
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology (2001) 0.84
Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease. Ann Neurol (2001) 0.82
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry (2003) 10.44
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88
Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA (2009) 8.40
Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell (2003) 7.71
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science (2005) 7.03
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet (2008) 6.97
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol (2008) 6.76
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet (2008) 5.93
Runs of homozygosity in European populations. Am J Hum Genet (2008) 5.34
Association of coffee drinking with total and cause-specific mortality. N Engl J Med (2012) 5.31
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med (2010) 5.27
Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med (2006) 4.95
No gene is an island: the flip-flop phenomenon. Am J Hum Genet (2007) 4.69
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry (2011) 4.29
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet (2010) 4.20
Genomic Control to the extreme. Nat Genet (2004) 4.19
Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychol Med (2005) 4.05
Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet (2002) 4.03
Amount of time spent in sedentary behaviors and cause-specific mortality in US adults. Am J Clin Nutr (2012) 3.95
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet (2007) 3.93
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol (2010) 3.84
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA (2003) 3.78
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69
Residential proximity to traffic and adverse birth outcomes in Los Angeles county, California, 1994-1996. Environ Health Perspect (2003) 3.66
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain (2010) 3.57
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet (2003) 3.55
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med (2010) 3.48
A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry (2006) 3.48
Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med (2008) 3.48
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology (2012) 3.46
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39
Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet (2008) 3.33
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet (2005) 3.29
Personality and comorbidity of common psychiatric disorders. Br J Psychiatry (2005) 3.27
Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol (2005) 3.27
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet (2008) 3.27
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol Med (2005) 3.19
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet (2012) 3.19
F-box proteins in rice. Genome-wide analysis, classification, temporal and spatial gene expression during panicle and seed development, and regulation by light and abiotic stress. Plant Physiol (2007) 3.18
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A (2007) 3.03
Characterization of multilocus linkage disequilibrium. Genet Epidemiol (2005) 3.03
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol (2009) 3.02
A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med (2004) 2.98
Age-related changes in heritability of behavioral phenotypes over adolescence and young adulthood: a meta-analysis. Twin Res Hum Genet (2007) 2.94